Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.63% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 1.29% |
| 4 | Communication Services | 0.93% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LDL
3801
PUT
DELISTED
Lydall, Inc.
LDL
| $5.28M | ﹤0.01% |
85,000
+24,900
| +41% | +$1.53M |
|
3802
CALL
Howard Hughes
HHH
$3.87B
| $5.28M | ﹤0.01% |
63,045
-2,308
| -4% | -$199K |
|
3803
PUT
US Foods
USFD
$23.2B
| $5.28M | ﹤0.01% |
152,200
+46,600
| +44% | +$1.6M |
|
|
FUV
3804
PUT
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $5.27M | ﹤0.01% |
23,070
+6,025
| +35% | +$1.64M |
|
3805
CALL
Royalty Pharma
RPRX
$27.1B
| $5.27M | ﹤0.01% |
145,800
-144,900
| -50% | -$5.63M |
|
3806
CALL
Aehr Test Systems
AEHR
$2.64B
| $5.26M | ﹤0.01% |
+385,700
| New | +$2.77M |
|
|
WWE
3807
DELISTED
World Wrestling Entertainment
WWE
| $5.26M | ﹤0.01% |
93,577
-57,521
| -38% | -$3M |
|
3808
CALL
Sociedad Química y Minera de Chile
SQM
$22.5B
| $5.26M | ﹤0.01% |
97,900
-77,200
| -44% | -$3.94M |
|
3809
PUT
Concentrix
CNXC
$1.79B
| $5.26M | ﹤0.01% |
29,700
+5,500
| +23% | +$911K |
|
3810
Northern Trust
NTRS
$34.2B
| $5.25M | ﹤0.01% |
48,657
-25,499
| -34% | -$2.89M |
|
|
TRIL
3811
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
| $5.24M | ﹤0.01% |
298,500
+186,900
| +167% | +$2.18M |
|
3812
PUT
Vanguard FTSE Developed Markets ETF
VEA
$238B
| $5.24M | ﹤0.01% |
103,800
+13,500
| +15% | +$702K |
|
|
EVRI
3813
CALL
DELISTED
Everi Holdings
EVRI
| $5.24M | ﹤0.01% |
216,600
+7,800
| +4% | +$178K |
|
3814
American Well
AMWL
$203M
| $5.23M | ﹤0.01% |
28,708
-3,789
| -12% | -$822K |
|
3815
CALL
Rekor Systems
REKR
$75.5M
| $5.23M | ﹤0.01% |
454,900
-274,900
| -38% | -$2.5M |
|
|
PDCE
3816
PUT
DELISTED
PDC Energy, Inc.
PDCE
| $5.23M | ﹤0.01% |
110,300
+17,300
| +19% | +$721K |
|
3817
PUT
SandRidge Energy
SD
$518M
| $5.22M | ﹤0.01% |
401,200
+320,400
| +397% | +$2.65M |
|
3818
Banco Macro
BMA
$4.86B
| $5.22M | ﹤0.01% |
307,188
+47,371
| +18% | +$749K |
|
3819
Ironwood Pharmaceuticals
IRWD
$682M
| $5.22M | ﹤0.01% |
399,534
+46,532
| +13% | +$601K |
|
3820
Acadia Pharmaceuticals
ACAD
$5.02B
| $5.21M | ﹤0.01% |
313,940
-218,034
| -41% | -$4.2M |
|
3821
PUT
Direxion Daily Healthcare Bull 3X ETF
CURE
$191M
| $5.21M | ﹤0.01% |
48,500
+29,500
| +155% | +$3.55M |
|
3822
CALL
Haemonetics
HAE
$4.73B
| $5.21M | ﹤0.01% |
73,800
+200
| +0.3% | +$12.6K |
|
3823
PUT
Ginkgo Bioworks
DNA
$469M
| $5.21M | ﹤0.01% |
+11,233
| New | +$5.47M |
|
|
SOHU
3824
PUT
Sohu.com
SOHU
$368M
| $5.2M | ﹤0.01% |
249,500
+192,700
| +339% | +$4.11M |
|
3825
Dycom Industries
DY
$8.88B
| $5.2M | ﹤0.01% |
72,976
-32,022
| -30% | -$2.26M |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.